Equity Research, Broker Reports, and media content on Shield Therapeutics Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Shield Therapeutics Plc

Company Profile

  • Personnel
  • Tim Watts, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics Plc. We currently have 180 research reports from 10 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 31.8/147p
  • Daily Volume: N/A
  • Daily Liquidity: (0.11%)
  • # Shares: 215.9m
  • Market Cap: £92.8m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
24Jun21 07:00 RNS Shield Therapeutics - US launch of Accrufer® confirmed for July 1, 2021
23Jun21 16:40 RNS Shield Therapeutics - Second Price Monitoring Extn
23Jun21 16:35 RNS Shield Therapeutics - Price Monitoring Extension
21Jun21 13:35 RNS Shield Therapeutics - Investor presentation
18Jun21 07:00 RNS Shield Therapeutics - Directorate Change
17Jun21 14:30 RNS Shield Therapeutics - Results of 2021 Annual General Meeting
15Jun21 18:15 RNS Shield Therapeutics - Grant of share options to the CEO
  • Frequency of research reports

     

  • Research reports on

    Shield Therapeutics Plc

  • Providers covering

    Shield Therapeutics Plc